5.4 Container Types, Puncture Limits & Multi-Dose Container Rules

Container Closure Architecture & Antimicrobial Preservatives

Commercial pharmaceutical packaging systems differ fundamentally in their vulnerability to microbial ingress. The presence or absence of an antimicrobial preservative system dictates how long a container may be stored and repeatedly entered once the manufacturer seal is breached.

1. Multiple-Dose Containers (MDCs)

• Definition: A container of sterile medication intended for parenteral administration that contains an antimicrobial preservative system (e.g., benzyl alcohol, methylparaben, phenol) validated to inhibit microbial proliferation over multiple entries.
• The 28-Day Rule: Under USP <797>, once a conventionally manufactured MDC is first punctured or entered, it must not be used for more than 28 days, unless the manufacturer's labeling specifies otherwise.
• Labeling Practice: Facilities write the date first opened and the resulting in-use date on the container. This is a CDC and accreditation expectation rather than USP <797> text.

Single-Dose Containers (SDCs) and Vials

A Single-Dose Container (SDC) is designed for parenteral, ophthalmic, or otic administration in a single patient. SDCs lack antimicrobial preservatives. Once breached, any introduced bacteria or fungi can multiply rapidly.

Puncture and Storage Rules for SDC Vials

• Entered only in ISO Class 5 Air: If a single-dose vial is entered or punctured only in ISO Class 5 or cleaner air, it may be used for up to 12 hours after the first puncture, as long as its labeled storage conditions are kept. USP's FAQ says the vial may be stored outside the PEC between entries, but every entry must be made inside ISO Class 5 air.
• Entered in Worse than ISO Class 5 Air: The 12-hour allowance does not apply. The vial is used for the preparation at hand and the remainder is discarded. Under the immediate-use provision, leftover single-dose components are discarded when the preparation is complete.
• Compromised Closures: A vial whose septum or metal ring has been removed, or an opened plastic luer-lock vial, is treated like an ampule and cannot be stored (USP FAQ).

Glass Ampules: Zero Storage Permitted

Glass ampules are single-dose containers without septa. Opening an ampule involves fracturing glass, exposing fluid directly to air:

• Immediate Use Only: Once an ampule is opened, its contents must be drawn up immediately.
• No Storage: Any unused fluid remaining in an ampule must be discarded immediately. It cannot be stored for 12 hours, even if maintained continuously within an ISO Class 5 laminar airflow hood.

---

Pharmacy Bulk Packages (PBPs)

A Pharmacy Bulk Package (PBP) is a container of a sterile preparation for parenteral use that contains many single doses. Common examples include large 2-liter bags of sterile water for injection, amino acid stock bottles, and large-volume concentrated electrolytes used in automated compounding devices (ACDs).

Operating Mandates for PBPs

• ISO 5 Requirement: A PBP must be entered or punctured only within an ISO Class 5 PEC.
• Transfer Protocol: The PBP is used exclusively to prepare sterile admixtures using a sterile transfer set or automated compounding device.
• Beyond-Use Duration: PBPs are used according to the manufacturer's labeling. Some labeling gives a long stability time (for example, 14 days) and a shorter in-use time based on microbial risk (for example, 4 hours). USP's FAQ says the shorter time governs. The 2008 chapter's default of 6 hours is no longer in USP <797>.

---

Clinical Toxicities of Antimicrobial Preservatives

While antimicrobial preservatives inhibit microbial proliferation in multiple-dose containers, they present serious clinical and toxicological risks in specific patient populations:

1. Neonatal Gasping Syndrome (Benzyl Alcohol)

Benzyl alcohol is a common bacteriostatic preservative in multi-dose sodium chloride, sterile water, and heparin flushes. In neonates—particularly premature and low-birth-weight infants—immature hepatic alcohol dehydrogenase and glycine conjugation pathways fail to metabolize benzyl alcohol efficiently. The resulting toxic accumulation of benzoic acid produces gasping syndrome, characterized by severe metabolic acidosis, encephalopathy, respiratory failure with gasping respirations, renal impairment, and cardiovascular collapse.

2. Neuraxial Neurotoxicity (Intrathecal and Epidural Administration)

Administration of compounded medications into the cerebrospinal fluid (intrathecal) or epidural space directly exposes delicate neural tissue without blood-brain barrier protection. Preservatives such as benzyl alcohol, parabens, and phenol induce direct neurotoxic damage, chemical arachnoiditis, demyelination, and permanent paraplegia. All neuraxial compounded preparations must be formulated using certified preservative-free commercial components.

3. Lipid Injectable Emulsion and Propofol Hang-Time Limits

Lipid injectable emulsions (such as 10%, 20%, and 30% IVLE) and propofol lack bacteriostatic preservatives and possess a neutral-to-alkaline pH that supports rapid microbial proliferation:

• Propofol Bottles/Vials: When spiked directly from the manufacturer vial, administration must be completed within 12 hours.
• Propofol Syringes: Compounded or transferred into syringes, administration must be completed within 6 hours.
• Intravenous Lipid Emulsions (IVLE): When infused separately, the infusion hang time is strictly limited to 12 hours.
• Total Nutrient Admixtures (3-in-1 TNAs): Infusion hang time is permitted up to 24 hours because the amino acid and dextrose components provide buffer and hypertonic protection.